期刊文献+

比索洛尔与培哚普利长期联合对慢性心力衰竭患者血浆BNP水平干预作用研究 被引量:2

The intervention of combination of bisoprolol and perindopril effecting on the plasma concentration of perindopril chronic heart failure patients
下载PDF
导出
摘要 目的:探讨比索洛尔与培哚普利长期联合治疗慢性心力衰竭对BNP水平的影响。方法:按照随机原则将54例慢性心力衰竭患者分为治疗组和对照组。治疗组28例在给予常规治疗慢性心力衰竭的基础上加用培哚普利4 mg/d,比索洛尔1.25~5 mg/d;对照组26例给予常规治疗慢性心力衰竭。两组共治疗4个月,观察治疗前与治疗后两组患者的BNP水平、EF、CI、6 min步行距离的变化。结果:治疗组治疗慢性心力衰竭的总有效率为92.9%,对照组治疗慢性心力衰竭的总有效率为53.8%,治疗前后的两组比较,BNP水平、EF、CI、6 min步行距离,差异均有统计学意义(P<0.05),治疗组疗效优于对照组。结论:比索洛尔与培哚普利长期联合能提高治疗慢性心力衰竭的疗效。 Objective To explore the intervention of combination of bisoprolol and perindopril effecting on the plasma concentration of perindopril chronic heart failure patients.Methods 54 cases of chronic heart failure patients were randomly divided into two groups,they are treatment group and control group.The 28 patients in treatment group were accepted added perindopril and bisoprolol treating based on the conventional treatment,add with a 4 mg/d,bisoprolol 1.25~5 mg/d;the 26 patients in the control group were accepted conventional therapy.The time of treatment in both groups was 4 months,the indexes of BNP levels,EF,CI,6 min walk distance changes were compared before and after the treatment.Results The total effective rate in the treatment group was 92.9%,it was higher than that in the control group(53.8%),they were showed significant difference.The indexes of BNP levels,EF,CI,6 min walk distance changes were better than that before treatment.They were also showed significant differences(P0.05).Conclusion The total effective rate could be significantly improved after treatment of combination of bisoprolol and perindopril based on conventional treatment.
出处 《吉林医学》 CAS 2011年第21期4343-4344,共2页 Jilin Medical Journal
关键词 慢性心力衰竭 比索洛尔 培哚普利 联合治疗 Chronic heart failure Bisoprolol Perindopril Combination therapy
  • 相关文献

参考文献4

二级参考文献23

  • 1吴小盈,沈冰,蒋文平,宋建平.慢性心力衰竭患者血浆B型利钠肽的测定及治疗的影响[J].心血管康复医学杂志,2005,14(6):527-529. 被引量:33
  • 2A report of ACC/AHA task force on practice guidelines (committee to revise the 1995 guidelines for the evaluation and management of heart failure) . ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adults:executive summary [J]. J Am Coll Cardiol,2001, 38(7):2101 -2113
  • 3Packer M, Carver J R, Rodeheffer R J, et al. Prospective randomized milrinone survival evaluation trial [J]. N Engl J Med,1991, 325:1468 - 1475
  • 4The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure [J]. N Engl J Med, 1997, 336:525 - 533
  • 5Cleland JG, McGowan J, Clark A. The evidence for beta blockers in heart failure [J]. BMJ, 1999, 318(7187): 824 - 825
  • 6The SOLVD Investigator. Studies Of Left Ventricular Dysfunction (SOLVD): rationale, design, and methods. 2 trials that evaluate the effect of enalapril in patients with reduced ejection fraction[J]. Am J Cardiol, 1990, 66:315 - 322
  • 7Pfeffer M A, Braunwald E, Moye L A, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival And Ventricular Enlargement trial [J] . N Engl J Med, 1992, 327:669 - 677
  • 8The AIRE Study Investigator. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction clinical evidence of heart failure [J]. Lancet, 1993, 342:821 - 828
  • 9Torp-Pedersen C, Kober I, for the TRACE Study Group. Effect of ACE inhibitor trandolapril on life expectancy of patients with reduced left ventricular after acute myocardial infarction [J] .Lancet, 1999, 354:9 - 12
  • 10The CONSENSUS trial study group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)[J]. N Engl J Med, 1987, 316:1429 - 1435

共引文献370

同被引文献11

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部